Actively Recruiting

All Genders
NCT05153694

Infectious Complications After Cystectomy: A Prospective Observational Study

Led by Ludwig-Maximilians - University of Munich · Updated on 2024-09-19

200

Participants Needed

1

Research Sites

213 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Patients undergoing cystectomy for either oncological or non-oncological indications are prospectively enrolled following informed consent. This study design incorporates a comprehensive medical history, detailed prospective documentation of clinicopathological parameters, and serial measurements of infectious markers pre- and post-operatively. In-hospital complications are meticulously recorded, and long-term outcomes assessed through structured follow-up interviews at 3, 6, and 12 months. These follow-ups utilize standardized questionnaires to evaluate post-discharge infectious complications and gather patients' perspectives on their in-hospital experiences, providing a robust understanding of both clinical outcomes and patient-reported experiences.

CONDITIONS

Official Title

Infectious Complications After Cystectomy: A Prospective Observational Study

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Disease which requires removal of the urinary bladder
Not Eligible

You will not qualify if you...

  • Patient does not want to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Urology Department - LMU Klinikum

Munich, Outside U.S./Canada, Germany, 81377

Actively Recruiting

Loading map...

Research Team

B

Benedikt Ebner, Dr.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here